Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 AUD | +1.38% | -1.10% | +28.57% |
Apr. 15 | Euroz Hartleys Adjusts Genus Plus’ Price Target to AU$2.16 From AU$1.83, Keeps at Buy | MT |
Apr. 15 | Genusplus Group Increases FY24 EBITDA Growth Guidance | MT |
Valuation
Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 146.3 | 224.5 | 199.1 | 322.6 | - | - |
Enterprise Value (EV) 1 | 118.6 | 224.5 | 180 | 311.1 | 300.1 | 284.7 |
P/E ratio | - | 15.2 x | - | - | 13.6 x | 9.31 x |
Yield | 1.91% | - | 1.79% | 1.21% | 2.56% | 2.62% |
Capitalization / Revenue | 0.46 x | - | 0.45 x | 0.64 x | 0.55 x | 0.45 x |
EV / Revenue | 0.37 x | - | 0.41 x | 0.61 x | 0.51 x | 0.4 x |
EV / EBITDA | 3.66 x | - | 4.89 x | 6.91 x | 5.67 x | 4.37 x |
EV / FCF | -38.1 x | - | 5.65 x | 45.4 x | 13.6 x | 10.5 x |
FCF Yield | -2.63% | - | 17.7% | 2.2% | 7.33% | 9.48% |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 155,590 | 176,752 | 177,725 | 177,725 | - | - |
Reference price 2 | 0.9400 | 1.270 | 1.120 | 1.815 | 1.815 | 1.815 |
Announcement Date | 8/29/21 | 8/31/22 | 8/21/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: Juni | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | 170 | 318.2 | - | 444.2 | 506.8 | 590.5 | 715.5 |
EBITDA 1 | - | 32.41 | - | 36.79 | 45 | 52.9 | 65.1 |
EBIT 1 | - | 24.99 | - | 18.45 | 30.4 | 35.5 | 44.45 |
Operating Margin | - | 7.85% | - | 4.15% | 6% | 6.01% | 6.21% |
Earnings before Tax (EBT) | - | 19.15 | - | - | - | 34 | 49 |
Net income 1 | 10.69 | 13.35 | 13.56 | 13.41 | 16.85 | 26.3 | 30.4 |
Net margin | 6.29% | 4.19% | - | 3.02% | 3.32% | 4.45% | 4.25% |
EPS | - | - | 0.0836 | - | - | 0.1330 | 0.1950 |
Free Cash Flow 1 | - | -3.116 | - | 31.84 | 6.85 | 22 | 27 |
FCF margin | - | -0.98% | - | 7.17% | 1.35% | 3.73% | 3.77% |
FCF Conversion (EBITDA) | - | - | - | 86.54% | 15.22% | 41.59% | 41.47% |
FCF Conversion (Net income) | - | - | - | 237.51% | 40.65% | 83.65% | 88.82% |
Dividend per Share 2 | - | 0.0180 | - | 0.0200 | 0.0220 | 0.0465 | 0.0475 |
Announcement Date | 12/11/20 | 8/29/21 | 8/31/22 | 8/21/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2023 S1 | 2024 S2 | 2025 S1 | 2026 S1 |
---|---|---|---|---|
Net sales 1 | 224.5 | 248.7 | 289 | 383 |
EBITDA 1 | - | 23 | 25 | 34 |
EBIT 1 | - | 15.8 | 16 | 23 |
Operating Margin | - | 6.35% | 5.54% | 6.01% |
Earnings before Tax (EBT) | - | - | 16 | 23 |
Net income | - | - | 11 | 16 |
Net margin | - | - | 3.81% | 4.18% |
EPS | - | - | - | - |
Dividend per Share 2 | - | 0.0290 | - | - |
Announcement Date | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - |
Net Cash position 1 | - | 27.6 | - | 19 | 11.5 | 22.5 | 37.9 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | -3.12 | - | 31.8 | 6.85 | 22 | 27 |
ROE (net income / shareholders' equity) | - | 34.3% | - | 13.5% | 18.8% | 19.6% | 21.2% |
ROA (Net income/ Total Assets) | - | 13% | - | 5.84% | 9.05% | 9.7% | 10.9% |
Assets 1 | - | 102.6 | - | 229.7 | 186.2 | 271.1 | 280.2 |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | 0.0500 | - | - | - | - | - |
Capex 1 | - | 10.1 | - | 5.7 | 8.95 | 11 | 11 |
Capex / Sales | - | 3.18% | - | 1.28% | 1.77% | 1.86% | 1.54% |
Announcement Date | 12/11/20 | 8/29/21 | 8/31/22 | 8/21/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+28.57% | 216M | |
+2.55% | 72.3B | |
-3.31% | 56.18B | |
+25.48% | 39.64B | |
+14.76% | 31.81B | |
+13.26% | 29.77B | |
+17.08% | 21.26B | |
+17.18% | 19.95B | |
+38.51% | 17.58B | |
+78.99% | 18.12B |
- Stock Market
- Equities
- GNP Stock
- Financials GenusPlus Group Limited